Histogen Inc. Quarterly Debt-to-equity in % from Q1 2021 to Q3 2023

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Histogen Inc. quarterly Debt-to-equity history and growth rate from Q1 2021 to Q3 2023.
Histogen Inc. Debt-to-equity for the quarter ending September 30, 2023 was 44.7 %, a 28.5% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2023	44.7	+9.93	+28.5%	Sep 30, 2023
Q2 2023	43.3	+8.48	+24.4%	Jun 30, 2023
Q1 2023	38.9	+6.28	+19.2%	Mar 31, 2023
Q4 2022	36.3	+4.73	+15%	Dec 31, 2022
Q3 2022	34.8	-3.57	-9.3%	Sep 30, 2022
Q2 2022	34.8	-12.3	-26.1%	Jun 30, 2022
Q1 2022	32.6	-35.7	-52.2%	Mar 31, 2022
Q4 2021	31.5			Dec 31, 2021
Q3 2021	38.4			Sep 30, 2021
Q2 2021	47.1			Jun 30, 2021
Q1 2021	68.3			Mar 31, 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.